- Home
- CTMX vs RFM Comparison
CTMX vs RFM Comparison
Compare CTMX & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- RFM
- Stock Information
- Founded
- CTMX 2008
- RFM 2020
- Country
- CTMX United States
- RFM United States
- Employees
- CTMX N/A
- RFM N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- RFM Finance/Investors Services
- Sector
- CTMX Health Care
- RFM Finance
- Exchange
- CTMX Nasdaq
- RFM Nasdaq
- Market Cap
- CTMX 444.3M
- RFM 86.0M
- IPO Year
- CTMX 2015
- RFM N/A
- Fundamental
- Price
- CTMX $2.42
- RFM $14.01
- Analyst Decision
- CTMX Strong Buy
- RFM
- Analyst Count
- CTMX 2
- RFM 0
- Target Price
- CTMX $5.00
- RFM N/A
- AVG Volume (30 Days)
- CTMX 2.4M
- RFM 20.7K
- Earning Date
- CTMX 08-07-2025
- RFM 01-01-0001
- Dividend Yield
- CTMX N/A
- RFM 9.74%
- EPS Growth
- CTMX 128.27
- RFM N/A
- EPS
- CTMX 0.49
- RFM N/A
- Revenue
- CTMX $147,557,000.00
- RFM N/A
- Revenue This Year
- CTMX N/A
- RFM N/A
- Revenue Next Year
- CTMX N/A
- RFM N/A
- P/E Ratio
- CTMX $5.36
- RFM N/A
- Revenue Growth
- CTMX 23.81
- RFM N/A
- 52 Week Low
- CTMX $0.40
- RFM $12.89
- 52 Week High
- CTMX $3.10
- RFM $16.41
- Technical
- Relative Strength Index (RSI)
- CTMX 52.71
- RFM 47.21
- Support Level
- CTMX $2.33
- RFM $14.01
- Resistance Level
- CTMX $2.79
- RFM $14.13
- Average True Range (ATR)
- CTMX 0.18
- RFM 0.09
- MACD
- CTMX -0.01
- RFM 0.02
- Stochastic Oscillator
- CTMX 46.38
- RFM 56.40
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.